Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF with Trastuzumab for Herceptin-Resistant Metastatic Breast Cancer
NCT00429104Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2002
- Primary completion
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2002; status: completed.
02
Drugs
sargramostim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00429104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429104.